These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Female puberty: clinical implications for the use of prolactin-modulating psychotropics.
    Author: Becker AL, Epperson CN.
    Journal: Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):207-20. PubMed ID: 16321731.
    Abstract:
    During puberty, girls may present with psychiatric illness necessitating treatment with psychotropic medications. Pubertal girls are especially vulnerable to medication-associated adverse events. Atypical antipsychotics and antidepressants have the potential to elevate prolactin levels, altering pubertal progression. Selection of prolactin-sparing atypical antipsychotics is recommended, as is treatment with the lowest effective dose of selective serotonin reuptake inhibitors. Monitoring of serum prolactin levels may be necessary.
    [Abstract] [Full Text] [Related] [New Search]